Drug intelligence / Profile preview

BioFoam

Development stage
Unknown
Lead developer
MicroPort
Modality
Recombinant Proteins and Enzymes, Small Molecules, Device-based Delivery → Drug Delivery Systems
Administration
Topical
01

Overview

BioFoam is a brand name used for two distinct medical technologies. Primarily, in surgical contexts, **BioFoam Surgical Matrix** is a protein-based hemostatic sealant developed by Artivion (formerly CryoLife). It consists of bovine serum albumin (BSA) and a glutaraldehyde cross-linking agent. Upon application, the glutaraldehyde reacts with the BSA and tissue proteins to create a flexible, high-strength foam that provides a mechanical seal to control bleeding in cardiovascular and hepatic surgeries. Separately, in orthopedic contexts, **BioFoam** refers to a porous titanium metal technology (marketed by MicroPort and formerly Wright Medical) used as a coating for joint replacement components (e.g., in the EVOLUTION and DYNASTY systems). This foam-like metal structure is designed to mimic cancellous bone, facilitating biological bone ingrowth to improve the long-term fixation of hip and knee implants. Additionally, the term is used generically in academic research for a variety of sustainable, bio-based foam materials derived from sources like alginate, starch, or fungal mycelium.

Brand names
BioFoamBioFoam Surgical MatrixEVOLUTION BioFoamDYNASTY BioFoam
Other names
BioFoam Surgical MatrixBiofoam Porous MetalBiofoam Advance

Beyond the preview

Go deeper on BioFoam.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioFoam.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call